• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain

byPaary BalakumarandAlex Chan
August 15, 2025
in Chronic Disease, Orthopedic Surgery, Rheumatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months, particularly in older patients

2. Pain location and baseline health status are not reliable indicators of whether a patient will continue medical cannabis use.

Evidence Rating Level: 3 (Average)

In this retrospective study, 78 patients with chronic musculoskeletal pain certified for medical cannabis (MC) at a single orthopedic institute between October 2022 and December 2024 were followed for up to one year to assess discontinuation rates and associated factors. Demographics, pain origin, and baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Global Physical Health (GPH) and Global Mental Health (GMH) scores were collected. Discontinuation status was confirmed through follow-up visits and the state MC registry. At three months, 44.7% of patients had discontinued MC, primarily due to dissatisfaction, preference for alternative treatments, or surgical intervention. By one year, 57.9% had ceased use, with older age significantly associated with discontinuation (mean 71.5 vs. 64.5 years; p = 0.04). Pain origin, including low back pain, did not significantly differ between those continuing and discontinuing, and baseline GPH/GMH scores were similar in both groups. These findings suggest that over half of patients stop MC within a year, with older adults more likely to discontinue, and that baseline health status and pain location are not strong predictors of adherence. Further research is warranted to identify modifiable factors that could improve long-term MC use for chronic musculoskeletal pain.

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

Combined use of cannabis and alcohol may increase driving impairment and subjective intoxication

2 Minute Medicine Rewind May 4, 2026

Repetitive transcranial magnetic stimulation may reduce the incidence of chronic postsurgical pain after thoracoscopic surgery

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: cannabischronic painmskmusculoskeletal painpain
Previous Post

#VisualAbstract: Riociguat Improves Exercise Following Balloon Pulmonary Angioplasty in Patients with Pulmonary Hypertension

Next Post

2 Minute Medicine Rewind August 18, 2025

RelatedReports

Systematic review examines benefits and adverse effects of cannabinoid therapy
Emergency

Combined use of cannabis and alcohol may increase driving impairment and subjective intoxication

May 8, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Brain lesions on MRI linked with subsequent increased stroke risk
Imaging and Intervention

Repetitive transcranial magnetic stimulation may reduce the incidence of chronic postsurgical pain after thoracoscopic surgery

April 14, 2026
Mindfulness-based therapy associated with improvement in quality of life for PTSD patients
Weekly Rewinds

2 Minute Medicine Rewind April 13, 2026

April 13, 2026
Next Post
Few high school students, young adults get HIV testing

2 Minute Medicine Rewind August 18, 2025

Tramadol use linked with increased risk of hypoglycemia hospitalizations

Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Two scores for risk stratification of adults presenting with syncope may be effective at identifying those with low risk
  • Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality
  • A novel therapy targeting γ-aminobutyric acid is safe and may be effective in major depressive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.